Amniotic Fluid Abnormalities Thesis Topics in OBGY

Amniotic Fluid Abnormalities

This page covers amniotic fluid abnormalities thesis topics across oligohydramnios, polyhydramnios, borderline amniotic fluid volume, assessment and measurement of amniotic fluid volume, and amniotic fluid abnormalities in high-risk pregnancies for MD Obstetrics and Gynaecology candidates. The emphasis is on amniotic fluid abnormalities research topics that can be completed within one thesis period using antenatal patients, ultrasonography, Doppler, cardiotocography, delivery records and immediate neonatal data already available in a teaching hospital, without requiring prolonged follow-up. A shortlisted question should then be converted into a focused obstetrics and gynaecology protocol and a submission-ready obstetrics and gynaecology synopsis.

Last reviewed and updated: September 2026 · 2026–27 admissions

Oligohydramnios

  1. Maternal and Foetal Factors Associated With Oligohydramnios in Singleton Pregnancies Beyond 28 Weeks of Gestation: A Cross-Sectional Analytical Study.
  2. Association Between Oligohydramnios and Adverse Intrapartum Foetal Heart Rate Patterns in Term Pregnancies: A Prospective Observational Study.
  3. Comparison of Maternal and Perinatal Characteristics in Term Pregnancies With and Without Oligohydramnios: A Comparative Cross-Sectional Study.
  4. Association Between Severity of Oligohydramnios and Mode of Delivery Among Women With Term Singleton Pregnancies: A Cross-Sectional Analytical Study.
  5. Correlation of Amniotic Fluid Index With Birth Weight in Pregnancies Complicated by Oligohydramnios: A Prospective Observational Study.
  6. Association Between Oligohydramnios and Meconium-Stained Amniotic Fluid in Term Pregnancies: A Cross-Sectional Analytical Study.
  7. Maternal Risk Factors Associated With Isolated Oligohydramnios at Term: A Cross-Sectional Observational Study.
  8. Comparison of Foetal Doppler Velocimetry Findings in Pregnancies With Isolated Oligohydramnios and Pregnancies With Normal Amniotic Fluid Volume: A Comparative Cross-Sectional Study.
  9. Correlation Between Amniotic Fluid Index and Umbilical Artery Doppler Parameters in Pregnancies Complicated by Oligohydramnios: A Cross-Sectional Analytical Study.
  10. Association of Oligohydramnios With Placental Grading and Placental Location in Third-Trimester Singleton Pregnancies: A Cross-Sectional Observational Study.
  11. Clinical and Ultrasonographic Profile of Women Presenting With Oligohydramnios During the Third Trimester: A Cross-Sectional Observational Study.
  12. Association Between Maternal Hypertensive Disorders and Severity of Oligohydramnios in Singleton Pregnancies: A Cross-Sectional Analytical Study.
  13. Comparison of Induction of Labour Outcomes in Term Pregnancies With Isolated Oligohydramnios and Normal Amniotic Fluid Volume: A Prospective Observational Study.
  14. Association Between Gestational Age at Diagnosis and Severity of Oligohydramnios in Third-Trimester Pregnancies: A Cross-Sectional Analytical Study.
  15. Correlation of Maternal Hydration Status With Amniotic Fluid Index Among Pregnant Women Diagnosed With Oligohydramnios: A Cross-Sectional Analytical Study.
  16. Association Between Oligohydramnios and Small-for-Gestational-Age Foetuses in Singleton Pregnancies: A Comparative Cross-Sectional Study.
  17. Relationship Between Reduced Amniotic Fluid Volume and Non-Reassuring Antenatal Cardiotocographic Findings at Term: A Cross-Sectional Analytical Study.
  18. Association Between Oligohydramnios and Caesarean Delivery for Foetal Distress in Term Singleton Pregnancies: A Prospective Observational Study.
  19. Correlation Between Amniotic Fluid Index and Estimated Foetal Weight in Pregnancies With Reduced Amniotic Fluid Volume: A Cross-Sectional Study.
  20. Obstetric and Immediate Neonatal Characteristics of Term Pregnancies Complicated by Isolated Oligohydramnios: A Prospective Observational Study.

Polyhydramnios

  1. Maternal and Foetal Factors Associated With Polyhydramnios in Singleton Pregnancies: A Cross-Sectional Analytical Study.
  2. Clinical and Ultrasonographic Profile of Pregnancies Complicated by Polyhydramnios at a Tertiary-Care Centre: A Cross-Sectional Observational Study.
  3. Association Between Severity of Polyhydramnios and Maternal Diabetes Mellitus in Singleton Pregnancies: A Cross-Sectional Analytical Study.
  4. Comparison of Obstetric Characteristics in Pregnancies With Mild Polyhydramnios and Normal Amniotic Fluid Volume: A Comparative Cross-Sectional Study.
  5. Association Between Polyhydramnios and Foetal Congenital Anomalies Detected on Antenatal Ultrasonography: A Cross-Sectional Analytical Study.
  6. Correlation Between Amniotic Fluid Index and Estimated Foetal Weight in Pregnancies Complicated by Polyhydramnios: A Cross-Sectional Analytical Study.
  7. Association Between Polyhydramnios and Foetal Macrosomia Among Women With and Without Gestational Diabetes Mellitus: A Comparative Cross-Sectional Study.
  8. Maternal Clinical Characteristics Associated With Idiopathic Polyhydramnios in the Third Trimester: A Cross-Sectional Observational Study.
  9. Comparison of Mode of Delivery in Term Pregnancies With Polyhydramnios and Normal Amniotic Fluid Volume: A Prospective Observational Study.
  10. Association Between Degree of Polyhydramnios and Malpresentation at Term: A Cross-Sectional Analytical Study.
  11. Relationship Between Polyhydramnios and Preterm Labour Among Singleton Pregnancies Presenting to a Tertiary-Care Hospital: A Cross-Sectional Analytical Study.
  12. Association Between Polyhydramnios and Abnormal Foetal Presentation in Third-Trimester Pregnancies: A Cross-Sectional Observational Study.
  13. Comparison of Maternal and Immediate Neonatal Characteristics Between Idiopathic and Secondary Polyhydramnios: A Comparative Cross-Sectional Study.
  14. Correlation Between Maternal Glycaemic Parameters and Amniotic Fluid Index in Pregnancies Complicated by Gestational Diabetes Mellitus and Polyhydramnios: A Cross-Sectional Analytical Study.
  15. Association Between Polyhydramnios and Caesarean Delivery in Term Singleton Pregnancies: A Prospective Observational Study.
  16. Ultrasonographic Spectrum of Foetal Structural Abnormalities Associated With Moderate and Severe Polyhydramnios: A Cross-Sectional Observational Study.
  17. Relationship Between Severity of Polyhydramnios and Maternal Respiratory or Abdominal Discomfort at Presentation: A Cross-Sectional Analytical Study.
  18. Association Between Polyhydramnios and Large-for-Gestational-Age Foetuses in Singleton Pregnancies: A Comparative Cross-Sectional Study.
  19. Maternal and Obstetric Factors Associated With Idiopathic Polyhydramnios at Term: A Cross-Sectional Analytical Study.
  20. Comparison of Intrapartum Complications Among Women With Polyhydramnios and Women With Normal Amniotic Fluid Volume at Term: A Prospective Observational Study.

Borderline Amniotic Fluid Volume

  1. Maternal and Foetal Characteristics Associated With Borderline Amniotic Fluid Index in Term Singleton Pregnancies: A Cross-Sectional Analytical Study.
  2. Comparison of Obstetric Outcomes Between Pregnancies With Borderline and Normal Amniotic Fluid Index at Term: A Prospective Observational Study.
  3. Association Between Borderline Amniotic Fluid Index and Non-Reassuring Foetal Heart Rate Patterns During Labour: A Cross-Sectional Analytical Study.
  4. Correlation Between Borderline Amniotic Fluid Index and Estimated Foetal Weight in Third-Trimester Pregnancies: A Cross-Sectional Study.
  5. Comparison of Umbilical Artery Doppler Findings in Pregnancies With Borderline and Normal Amniotic Fluid Volume: A Comparative Cross-Sectional Study.
  6. Association Between Borderline Amniotic Fluid Index and Caesarean Delivery for Foetal Distress at Term: A Prospective Observational Study.
  7. Relationship Between Borderline Amniotic Fluid Volume and Small-for-Gestational-Age Foetuses in Singleton Pregnancies: A Cross-Sectional Analytical Study.
  8. Association Between Borderline Amniotic Fluid Index and Meconium-Stained Liquor During Labour: A Cross-Sectional Analytical Study.
  9. Comparison of Labour Induction Characteristics in Women With Borderline Amniotic Fluid Index and Women With Normal Amniotic Fluid Volume: A Prospective Observational Study.
  10. Correlation Between Amniotic Fluid Index and Placental Maturity in Pregnancies With Borderline Amniotic Fluid Volume: A Cross-Sectional Analytical Study.
  11. Maternal Risk Factors Associated With Borderline Amniotic Fluid Index in Late Pregnancy: A Cross-Sectional Observational Study.
  12. Association Between Maternal Hypertensive Disorders and Borderline Amniotic Fluid Volume in Third-Trimester Pregnancies: A Cross-Sectional Analytical Study.
  13. Comparison of Cardiotocographic Findings Between Term Pregnancies With Borderline Amniotic Fluid Index and Normal Amniotic Fluid Index: A Comparative Cross-Sectional Study.
  14. Relationship Between Borderline Amniotic Fluid Index and Low Birth Weight in Term Singleton Pregnancies: A Prospective Observational Study.
  15. Association Between Gestational Age and Prevalence of Borderline Amniotic Fluid Index Among Women Presenting After 34 Weeks of Pregnancy: A Cross-Sectional Study.
  16. Correlation of Maternal Body Mass Index With Amniotic Fluid Index Among Women With Borderline Amniotic Fluid Volume: A Cross-Sectional Analytical Study.
  17. Association Between Borderline Amniotic Fluid Index and Abnormal Cerebroplacental Ratio in Third-Trimester Singleton Pregnancies: A Cross-Sectional Analytical Study.
  18. Comparison of Immediate Neonatal Characteristics in Pregnancies With Borderline Amniotic Fluid Index and Oligohydramnios at Term: A Comparative Cross-Sectional Study.
  19. Relationship Between Borderline Amniotic Fluid Volume and Induction-to-Delivery Interval in Women Undergoing Labour Induction at Term: A Prospective Observational Study.
  20. Clinical Significance of Borderline Amniotic Fluid Index in Otherwise Low-Risk Term Singleton Pregnancies: A Cross-Sectional Analytical Study.

Assessment and Measurement of Amniotic Fluid Volume

  1. Comparison of Amniotic Fluid Index and Single Deepest Vertical Pocket for Detection of Reduced Amniotic Fluid Volume in Third-Trimester Singleton Pregnancies: A Comparative Cross-Sectional Study.
  2. Agreement Between Amniotic Fluid Index and Single Deepest Vertical Pocket Measurements in Assessment of Amniotic Fluid Volume at Term: A Cross-Sectional Agreement Study.
  3. Correlation Between Amniotic Fluid Index and Single Deepest Vertical Pocket Measurements Across Different Gestational Ages in the Third Trimester: A Cross-Sectional Analytical Study.
  4. Interobserver Variability in Ultrasonographic Measurement of Amniotic Fluid Index Among Third-Trimester Pregnancies: A Cross-Sectional Reliability Study.
  5. Interobserver Agreement in Measurement of the Single Deepest Vertical Pocket for Assessment of Amniotic Fluid Volume: A Cross-Sectional Reliability Study.
  6. Comparison of Amniotic Fluid Index Measurements Obtained Before and After Maternal Bladder Emptying in Third-Trimester Pregnancies: A Comparative Cross-Sectional Study.
  7. Association Between Maternal Body Mass Index and Ultrasonographic Amniotic Fluid Index Measurement in Singleton Pregnancies: A Cross-Sectional Analytical Study.
  8. Correlation Between Gestational Age and Ultrasonographically Measured Amniotic Fluid Index in Uncomplicated Third-Trimester Pregnancies: A Cross-Sectional Study.
  9. Comparison of Amniotic Fluid Index and Single Deepest Vertical Pocket in Identification of Polyhydramnios Among Singleton Pregnancies: A Diagnostic Agreement Study.
  10. Diagnostic Performance of Amniotic Fluid Index Compared With Single Deepest Vertical Pocket for Classification of Amniotic Fluid Abnormalities in the Third Trimester: A Cross-Sectional Diagnostic Study.
  11. Association Between Foetal Presentation and Distribution of Amniotic Fluid Pockets During Ultrasonographic Amniotic Fluid Index Assessment: A Cross-Sectional Observational Study.
  12. Relationship Between Placental Location and Ultrasonographic Amniotic Fluid Index Measurements in Singleton Pregnancies: A Cross-Sectional Analytical Study.
  13. Comparison of Amniotic Fluid Index Measurements Obtained by Two Independent Examiners in Women With Suspected Oligohydramnios: A Cross-Sectional Reliability Study.
  14. Correlation Between Amniotic Fluid Index and Foetal Biometric Parameters in Uncomplicated Third-Trimester Pregnancies: A Cross-Sectional Analytical Study.
  15. Comparison of Amniotic Fluid Volume Classification by Amniotic Fluid Index and Single Deepest Vertical Pocket in High-Risk Pregnancies: A Comparative Cross-Sectional Study.
  16. Association Between Maternal Position During Ultrasonography and Measured Amniotic Fluid Index in Third-Trimester Pregnancies: A Comparative Cross-Sectional Study.
  17. Relationship Between Ultrasonographic Amniotic Fluid Index and Foetal Urinary Bladder Volume in Third-Trimester Singleton Pregnancies: A Cross-Sectional Correlation Study.
  18. Correlation of Amniotic Fluid Index With Umbilical Artery Doppler Indices in High-Risk Singleton Pregnancies: A Cross-Sectional Analytical Study.
  19. Comparison of Amniotic Fluid Index Distribution in Low-Risk and High-Risk Third-Trimester Pregnancies: A Comparative Cross-Sectional Study.
  20. Association Between Maternal Hydration Status and Ultrasonographically Measured Amniotic Fluid Volume in Late Pregnancy: A Cross-Sectional Analytical Study.

Amniotic Fluid Abnormalities in High-Risk Pregnancies

  1. Prevalence and Pattern of Amniotic Fluid Abnormalities in Pregnancies Complicated by Hypertensive Disorders: A Cross-Sectional Observational Study.
  2. Association Between Severity of Pre-eclampsia and Amniotic Fluid Index in Third-Trimester Singleton Pregnancies: A Cross-Sectional Analytical Study.
  3. Correlation Between Amniotic Fluid Index and Umbilical Artery Doppler Parameters in Pregnancies Complicated by Pre-eclampsia: A Cross-Sectional Analytical Study.
  4. Comparison of Amniotic Fluid Volume in Pregnant Women With Gestational Diabetes Mellitus and Normoglycaemic Pregnant Women: A Comparative Cross-Sectional Study.
  5. Association Between Maternal Glycaemic Control and Polyhydramnios in Pregnancies Complicated by Gestational Diabetes Mellitus: A Cross-Sectional Analytical Study.
  6. Pattern of Amniotic Fluid Abnormalities in Pregnancies Complicated by Foetal Growth Restriction: A Cross-Sectional Observational Study.
  7. Correlation Between Amniotic Fluid Index and Estimated Foetal Weight in Pregnancies With Foetal Growth Restriction: A Cross-Sectional Analytical Study.
  8. Association Between Oligohydramnios and Abnormal Cerebroplacental Ratio in Pregnancies With Foetal Growth Restriction: A Cross-Sectional Analytical Study.
  9. Comparison of Amniotic Fluid Index in Women With Chronic Hypertension and Gestational Hypertension During the Third Trimester: A Comparative Cross-Sectional Study.
  10. Association Between Maternal Anaemia and Amniotic Fluid Abnormalities in Third-Trimester Singleton Pregnancies: A Cross-Sectional Analytical Study.
  11. Prevalence of Oligohydramnios Among Women With Postdated Pregnancies and Its Association With Intrapartum Foetal Heart Rate Abnormalities: A Prospective Observational Study.
  12. Comparison of Amniotic Fluid Volume in Term and Postdated Singleton Pregnancies: A Comparative Cross-Sectional Study.
  13. Association Between Reduced Amniotic Fluid Volume and Abnormal Umbilical Artery Doppler Findings in High-Risk Pregnancies: A Cross-Sectional Analytical Study.
  14. Relationship Between Maternal Thyroid Dysfunction and Amniotic Fluid Abnormalities in Singleton Pregnancies: A Cross-Sectional Analytical Study.
  15. Pattern of Amniotic Fluid Abnormalities Among Pregnant Women With Previous Caesarean Delivery Presenting at Term: A Cross-Sectional Observational Study.
  16. Association Between Amniotic Fluid Abnormalities and Foetal Malpresentation in High-Risk Third-Trimester Pregnancies: A Cross-Sectional Analytical Study.
  17. Comparison of Amniotic Fluid Index Between Pregnancies With Appropriate-for-Gestational-Age and Small-for-Gestational-Age Foetuses: A Comparative Cross-Sectional Study.
  18. Relationship Between Amniotic Fluid Index and Foetal Cerebroplacental Ratio in High-Risk Singleton Pregnancies: A Cross-Sectional Correlation Study.
  19. Association Between Abnormal Amniotic Fluid Volume and Non-Reassuring Cardiotocographic Findings in High-Risk Term Pregnancies: A Cross-Sectional Analytical Study.
  20. Clinical, Obstetric, and Ultrasonographic Profile of Amniotic Fluid Abnormalities Among High-Risk Pregnancies Presenting in the Third Trimester: A Cross-Sectional Observational Study.

Not the obstetrics and gynaecology subspeciality you need? Amniotic fluid abnormalities is one section of our full obstetrics and gynaecology collection — the hub page lists every subspeciality, each with its own free topic list. Updated September 2026.

All Obstetrics and Gynaecology Topics →

📌 Updated for 2026–2027 MD Obstetrics and Gynaecology Amniotic Fluid Abnormalities admissions

The content has been reviewed for current definitions of oligohydramnios and polyhydramnios, measurement methods, high-risk pregnancy associations and thesis-period feasibility.

  • Most projects can be completed with routine antenatal ultrasonography, amniotic fluid index or single deepest vertical pocket measurement, foetal biometry, Doppler, cardiotocography and delivery records already generated during clinical care.
  • Research-only invasive testing, amniocentesis, additional radiation, expensive biomarkers or prolonged postnatal follow-up are not required for a strong resident thesis.
  • Publication potential is strongest when the fluid-measurement method is prespecified, isolated abnormalities are separated from placental or foetal disease, and intrapartum or immediate neonatal outcomes are defined before data collection.
Generate a protocol from any topic above

Select Generate Protocol → beside any title in the list above and receive a submission-ready document built around that topic, containing all eighteen components:

  • Introduction / Synopsis
  • Research Question
  • Aim of the Study
  • Primary Objective
  • Secondary Objectives
  • Materials and Methods
  • Inclusion Criteria
  • Exclusion Criteria
  • Sample Size Calculation
  • Methodology
  • Statistical Analysis
  • Ethical Considerations
  • Review of Literature
  • References
  • Gantt Chart / Study Timeline
  • Patient Information Sheet
  • Consent Form
  • Data Collection Form

Already have your thesis title?

Generate the full amniotic fluid abnormalities protocol directly — objectives, methodology, sample size, statistics, timeline, references and annexures.

Generate your protocol

Alongside amniotic fluid abnormalities protocols and synopses, support is also available for departmental presentations, journal club presentations, ethics committee presentations, and posters and oral presentations for medical conferences — for postgraduate residents, board trainees and research scholars across India and the GCC. Prepared by a practising doctor with long experience in medical publishing and thesis supervision.

Enquire on WhatsApp →

Amniotic fluid abnormalities research outside India

The topics above work as research questions anywhere — what changes is the document the institution expects, and who approves it before data collection begins. The Gulf equivalent of an Indian synopsis is the amniotic fluid abnormalities research proposal submitted to an institutional review board, and it ordinarily carries three sections an Indian synopsis does not: a Gantt chart, a budget and resources section, and a Declaration of Helsinki statement.

Board and residency programmes — country by country

Saudi Arabia — SCFHS and the Saudi Board. Residency and fellowship training under the Saudi Commission for Health Specialties includes a research project with a set timeline, and the amniotic fluid abnormalities research proposal is the document prepared at the outset and cleared by the institutional review board before recruitment starts.

United Arab Emirates — DHA, DOH Abu Dhabi and MOHAP. Residents training in Dubai, Abu Dhabi and the northern emirates prepare an amniotic fluid abnormalities research protocol for their programme and submit it for institutional review board approval before any data are collected.

Qatar — DHP (formerly QCHP) and Hamad Medical Corporation. A amniotic fluid abnormalities IRB proposal is reviewed before recruitment, with the ethics section written to the institution's own template rather than a generic one.

Bahrain — NHRA. Trainees turning amniotic fluid abnormalities research topics into a project need the proposal cleared by their institutional research and ethics committee before fieldwork begins.

Oman — OMSB. Residency programmes under the Oman Medical Specialty Board include a research component, and the amniotic fluid abnormalities research proposal is the document assessed at the start of it.

Kuwait — KIMS. A amniotic fluid abnormalities study protocol goes to the institutional committee for approval before the project begins.

Arab Board programmes across the region. The Arab Board carries its own research requirement irrespective of the host country, and the amniotic fluid abnormalities proposal follows the same structure throughout.

Generate an amniotic fluid abnormalities research proposal →

Postgraduate degrees — Malaysia, the Gulf and beyond

Malaysia — MMed, the National Medical Research Register and MREC. A amniotic fluid abnormalities dissertation proposal for a Master of Medicine programme carried out in a Ministry of Health facility must be registered on the NMRR and approved by the Medical Research and Ethics Committee before the study begins, and the guidance asks for submission four to six months ahead of data collection. Every investigator on the study team registers on the NMRR as well, so the methodology, ethics and team sections are written in far more detail than an Indian synopsis requires.

PhD and Master's candidates elsewhere. University programmes generally require a full amniotic fluid abnormalities research proposal of roughly 6,000 to 10,000 words, with an extended literature review, a theoretical framework and a detailed methodology chapter.

PhD and MMed proposals are written individually by a medical doctor and revised until the supervisor accepts them. They are not produced by the automated protocol generator.

Enquire about an amniotic fluid abnormalities PhD or MMed proposal →

🔥 Trending research areas in Amniotic Fluid Abnormalities for 2026–27

  • Amniotic fluid index versus single deepest vertical pocket: current work continues to examine how the chosen method changes classification of oligohydramnios and polyhydramnios and whether those differences lead to clinically meaningful changes in intervention.
  • Risk-stratified isolated oligohydramnios: combining fluid assessment with foetal growth, Doppler and placental-insufficiency markers may help distinguish constitutionally low fluid from pregnancies with genuine placental dysfunction.
  • Polyhydramnios phenotyping: separating idiopathic cases from diabetes-related, anomaly-associated and other secondary polyhydramnios is increasingly important because prognosis and obstetric management differ between these groups.
  • Reproducibility of semiquantitative fluid measurement: examiner variability, maternal position, foetal presentation and borderline measurements are practical research areas because small measurement changes can move a pregnancy across a clinical threshold.

Protocol and synopsis guidance

What an Amniotic Fluid Abnormalities protocol must contain

An amniotic fluid abnormalities protocol should define gestational-age limits, singleton or multiple pregnancy status, whether ruptured membranes are excluded, the exact fluid-measurement method and the thresholds used for oligohydramnios, borderline volume and polyhydramnios. The ultrasonographic technique should be standardised, including maternal position, avoidance of pockets containing umbilical cord or foetal parts, and whether measurements are performed by one examiner or several examiners.

Isolated and secondary abnormalities must be separated. Oligohydramnios associated with foetal growth restriction, hypertensive disease, ruptured membranes or congenital renal abnormalities is biologically different from isolated oligohydramnios at term. Likewise, polyhydramnios associated with diabetes, foetal anomaly or alloimmunisation should not be pooled uncritically with idiopathic polyhydramnios. The protocol should define these groups before recruitment rather than creating them after seeing the results.

Outcome timing must be fixed. Amniotic fluid is a time-varying measurement, so the protocol should state the interval allowed between the index ultrasound and labour, delivery, Doppler assessment or cardiotocography. If birth weight, meconium-stained liquor, intrapartum foetal heart-rate abnormalities, caesarean delivery or neonatal admission are outcomes, the exact definitions and ascertainment window should be prespecified.

Amniotic Fluid Abnormalities synopsis versus Amniotic Fluid Abnormalities protocol

The synopsis is the concise institutional submission describing the research question, objectives, design, population, fluid-measurement method and principal outcomes. The full protocol should additionally define gestational age at assessment, ultrasound technique, diagnostic thresholds, exclusion of ruptured membranes, criteria for isolated versus secondary fluid abnormality, Doppler and cardiotocographic definitions, delivery-outcome definitions and the acceptable interval between ultrasound and outcome assessment.

For comparative measurement studies, the protocol should state whether amniotic fluid index and single deepest vertical pocket are obtained during the same examination, whether the examiner is blinded to the first measurement when obtaining the second, and whether the objective is agreement, classification difference or prediction of an independent obstetric outcome. These are different questions and require different analyses.

Sample size and statistical analysis

Sample size should follow the primary objective. A prevalence study needs an expected proportion and desired precision; a comparison of pregnancies with and without oligohydramnios needs an expected difference in the prespecified outcome; and a study of measurement agreement requires a sample sufficient to estimate agreement with useful confidence. Studies using rare outcomes such as perinatal mortality as the primary endpoint usually require more participants than a single-centre postgraduate thesis can recruit.

Amniotic fluid index and single deepest vertical pocket should not automatically be analysed as though one were the gold standard for the other. When both are used to classify the same pregnancies, agreement can be assessed with percentage agreement and kappa, while continuous measurements can be explored with correlation only if the question is association rather than interchangeability. Correlation alone does not establish that two measurement methods agree.

Associations with birth weight, Doppler findings, cardiotocography, mode of delivery or neonatal outcomes should account for major confounders such as gestational age, hypertensive disorders, diabetes, foetal growth restriction and congenital anomalies. If several ultrasound measurements are taken from the same woman, repeated observations should not be treated as independent pregnancies.

Frequently Asked Questions – Amniotic Fluid Abnormalities (2026–27)

1. How do I choose a feasible Amniotic Fluid Abnormalities thesis topic for 2026 admission?

Choose a question around a fluid abnormality that is seen often enough in the unit and can be measured using routine antenatal care. Before registration, check the monthly number of eligible pregnancies, whether the department routinely records amniotic fluid index or single deepest vertical pocket, and whether Doppler, cardiotocography, mode of delivery, birth weight and immediate neonatal outcomes can be retrieved consistently. A focused question on oligohydramnios, polyhydramnios, borderline fluid or measurement agreement is usually more feasible than a project requiring prolonged infant follow-up.

2. Which study designs are accepted for Amniotic Fluid Abnormalities research?

Suitable designs include descriptive and analytical cross-sectional studies, comparative cross-sectional studies, prospective observational studies, retrospective cohorts, reliability or agreement studies and selected diagnostic or prognostic studies. The design should follow the question. A single ultrasound measurement with concurrent maternal or foetal characteristics can be cross-sectional, whereas an ultrasound measurement followed by labour, delivery or neonatal outcome is prospective or retrospective longitudinal work rather than a purely cross-sectional study.

3. What should I settle with my guide before registering an Amniotic Fluid Abnormalities topic?

Settle the gestational-age range, singleton or multiple pregnancy status, membrane status, fluid-measurement method, diagnostic thresholds, definition of isolated disease, primary outcome, ultrasound-to-delivery interval and important exclusion criteria. Also decide whether hypertensive disorders, diabetes, foetal growth restriction and congenital anomalies will be excluded, analysed separately or adjusted for, because these conditions can influence both amniotic fluid volume and obstetric outcomes.

4. Should I use Amniotic Fluid Index or Single Deepest Vertical Pocket in my thesis?

Use the method that matches the research question and the unit's clinical practice, and state it before recruitment. If the objective is to compare the two methods, obtain both during the same examination using a standardised technique and analyse their agreement and classification differences. Do not describe one as the definitive reference standard merely because it is more familiar. For oligohydramnios, the single deepest vertical pocket is often preferred in clinical surveillance because it identifies fewer pregnancies as oligohydramnios without evidence of worse perinatal outcome, but the thesis should follow the locally approved clinical pathway.

5. What is the difference between an Amniotic Fluid Abnormalities synopsis and protocol?

The synopsis is the shorter academic submission used for topic approval or institutional registration. The protocol is the detailed research plan that fixes participant selection, ultrasound timing, fluid-measurement technique, thresholds, grouping of isolated and secondary abnormalities, Doppler or cardiotocographic variables, delivery outcomes, confounders, data handling and statistical analysis. The final thesis should follow those definitions rather than redefining oligohydramnios, borderline fluid or polyhydramnios after examining the results.

6. What ethics issues are important in Amniotic Fluid Abnormalities research?

The protocol should state whether all ultrasonography, Doppler, cardiotocography and laboratory tests are part of routine antenatal care or whether the study adds any examination solely for research. Research should not expose pregnant participants or foetuses to additional ionising radiation, contrast administration or invasive procedures merely to complete a thesis. Research-only venepuncture should be avoided when routine laboratory values can answer the question; if additional blood sampling is necessary, the purpose and permitted blood volume should be stated explicitly.

Prospective participants should provide informed consent. If pregnant adolescents are eligible, guardian consent and age-appropriate assent from about seven years should be addressed according to institutional requirements and applicable law. Record-based work may qualify for an ethics-approved waiver of individual consent. Exported ultrasound images and DICOM files should be anonymised before analysis outside the clinical system, and separate consent is required for identifiable photographs or video. The protocol should also define the escalation pathway for newly detected severe oligohydramnios, marked polyhydramnios, foetal growth restriction, abnormal Doppler, congenital anomaly or another clinically important finding so that the obstetric team acts on it immediately rather than leaving it only in the research dataset.

7. What is the biggest methodological error in an Amniotic Fluid Abnormalities thesis?

The sharpest error is treating amniotic fluid index and single deepest vertical pocket as though one were a gold-standard diagnostic test for the other. Both are semiquantitative ultrasound estimates of a dynamic biological volume, and the same pregnancy can cross a diagnostic threshold depending on the method, examiner and timing. Calling disagreement a false-positive or false-negative result is therefore usually incorrect unless an independent clinically meaningful reference is defined.

A related error is ignoring how close the measurement lies to the chosen threshold. A small change caused by examiner technique, maternal position or the interval between scans can move a pregnancy from normal to borderline or oligohydramnios. The protocol should therefore prespecify the measurement method, classify technically adequate examinations consistently and separate agreement between methods from prediction of genuine obstetric or neonatal outcomes.

8. How does an Amniotic Fluid Abnormalities MD thesis differ from PhD and Gulf board research pathways?

An MD synopsis is usually a focused dissertation plan designed for completion during residency using a defined obstetric population and routinely available investigations. A PhD proposal is expected to justify a broader knowledge gap, a more extensive methodology and a programme of original research that may include multicentre recruitment, longitudinal follow-up or mechanistic work.

Residents outside the Indian MD pathway should align the project with the requirements of their training body. This includes the mandatory board research project required within SCFHS and Saudi Board training, Arab Board of Health Specializations research requirements, and institutional or programme research processes linked to DHP, DHA, DOH and MOHAP. The clinical question may remain similar, but submission format, supervision, ethics approval and completion milestones should follow the relevant programme.

9. When should I register my Amniotic Fluid Abnormalities thesis topic?

Register after confirming the expected number of eligible pregnancies, the exact fluid-measurement method, availability of the intended maternal, foetal and delivery variables, and agreement with the guide on the primary outcome and major confounders. Registration should occur before prospective recruitment or research-specific data collection begins. For retrospective work, fix the study period, eligibility criteria and analysis plan before extracting outcomes so that cases are not selected according to the results already known.

Found a topic that fits your department?

Generate its full protocol — objectives, methodology, sample size, statistics, timeline, references and annexures — in editable format.

Generate your protocol